Growth Metrics

Neurocrine Biosciences (NBIX) Inventory (2017 - 2021)

Historic Inventory for Neurocrine Biosciences (NBIX) over the last 5 years, with Q3 2021 value amounting to $25.5 million.

  • Neurocrine Biosciences' Inventory rose 2378.64% to $25.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $25.5 million, marking a year-over-year increase of 2378.64%. This contributed to the annual value of $28.0 million for FY2020, which is 6184.97% up from last year.
  • According to the latest figures from Q3 2021, Neurocrine Biosciences' Inventory is $25.5 million, which was up 2378.64% from $28.3 million recorded in Q2 2021.
  • In the past 5 years, Neurocrine Biosciences' Inventory ranged from a high of $30.1 million in Q1 2021 and a low of $128000.0 during Q2 2017
  • In the last 5 years, Neurocrine Biosciences' Inventory had a median value of $15.2 million in 2019 and averaged $15.4 million.
  • As far as peak fluctuations go, Neurocrine Biosciences' Inventory surged by 240165.29% in 2018, and later soared by 2378.64% in 2021.
  • Over the past 5 years, Neurocrine Biosciences' Inventory (Quarter) stood at $1.0 million in 2017, then soared by 960.94% to $10.9 million in 2018, then soared by 59.24% to $17.3 million in 2019, then skyrocketed by 61.85% to $28.0 million in 2020, then decreased by 8.93% to $25.5 million in 2021.
  • Its Inventory stands at $25.5 million for Q3 2021, versus $28.3 million for Q2 2021 and $30.1 million for Q1 2021.